Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firm's proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy and Chronic Hepatitis B. The company was founded in 1995 and is headquartered in Hayward, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
16
Frequently Asked Questions
What is Market Cap of Benitec Biopharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Benitec Biopharma Inc market cap is $365.14M.
What is the 52-week high for Benitec Biopharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Benitec Biopharma Inc 52 week high is $17.15 as of September 07, 2025.
What is the 52-week low for Benitec Biopharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Benitec Biopharma Inc 52 week low is $8.06 as of September 07, 2025.
What is Benitec Biopharma Inc stock price today?
Benitec Biopharma Inc stock price today is $13.91.
What was Benitec Biopharma Inc stock price yesterday?
Benitec Biopharma Inc stock price yesterday was $14.00.
What is the PE ratio of Benitec Biopharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Benitec Biopharma Inc’s P/E ratio is -8.80.
What is the Price-to-Book ratio of Benitec Biopharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Benitec Biopharma Inc P/B ratio is 3.6420.
What is the 50-day moving average of Benitec Biopharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Benitec Biopharma Inc 50-day moving average is $12.36.
How many employess does Benitec Biopharma Inc has?